Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Taro Pharmaceutical Industries Ltd (NYSE:TARO)

133.60
Delayed Data
As of Aug 31
 -1.31 / -0.97%
Today’s Change
124.35
Today|||52-Week Range
173.00
-9.85%
Year-to-Date
No recent news for Taro Pharmaceutical Industries Ltd.

Today’s Trading

Previous close134.91
Today’s open134.78
Day’s range132.88 - 135.58
Volume66,127
Average volume (3 months)66,453
Market cap$5.8B
Dividend yield--
Data as of 4:08pm ET, 08/31/2015

Growth & Valuation

Earnings growth (last year)+38.94%
Earnings growth (this year)+2.84%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+13.65%
P/E ratio--
Price/Sales7.00
Price/Book4.09

Competitors

 Today’s
change
Today’s
% change
ANACAnacor Pharmaceutica...-5.04-3.72%
OPKOPKO Health Inc-0.60-5.25%
SGENSeattle Genetics Inc-1.98-4.69%
HZNPHorizon Pharma PLC-1.26-4.13%
Data as of 4:03pm ET, 08/31/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$862.9M
Annual profit (last year)$484.3M
Net profit margin56.21%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Kal Sundaram
Vice President &
Operations Head-Haifa
Itamar karsenti
Corporate headquarters
Haifa Bay, Haifa

Forecasts

Partner Offers